The Janus face of polypharmacy - Overuse versus underuse of medication

Norsk Epidemiologi

Volumn 18, Issue 2, 2008, Pages 147-152

  Viktil, Kirsten K ^a,b   Blix, Hege Salvesen ^b,c   Reikvam, Åsmund ^b  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; CASE REPORT; CLINICAL RESEARCH; COMORBIDITY; DRUG INDUCED DISEASE; DRUG USE; DRUG UTILIZATION; ELDERLY CARE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; LITHIUM BLOOD LEVEL; MALE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; POLYARTHRITIS; POLYPHARMACY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 45549094002     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100: 428-37.
2. Denneboom W, Dautzenberg MG, Grol R, De Smet PA. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract 2007; 57: 723-31.
3. Fillit HM, Futterman R, Orland BI, Chim T, Susnow L, Picariello GP, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999; 5: 587-94.
4. Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther 2007; 32: 469-76.
5. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516-23.
6. Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Sen S, Kaboli PJ. Conflicts and concordance between measures of medication prescribing quality. Med Care 2007; 45: 95-9.
7. Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 1999; 49: 195-8.
8. Masoudi FA, Krumholz HM. Polypharmacy and comorbidity in heart failure. Br Med J 2003; 327: 513-4.
9. Wawruch M, Zikavska M, Wsolova L, Kuzelova M, Tisonova J, Gajdosik J, et al. Polypharmacy in elderly hospitalised patients in Slovakia. Pharm World Sci 2007; DOI 10.1007/s11096-007-9166-3.
10. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005; 31: 4-11.
11. Friel JP. Dorland's Illustrated Medical Dictionary, 25th edn. Saunders Company, 1974.
12. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17: 123-32.
13. Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997; 53: 7-11.
14. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005; 25: 1636-45.
15. Brager R, Sloand E. The spectrum of polypharmacy. Nurse Pract 2005; 30: 44-50.
16. Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005; 5: 26.
17. Fastbom J. Increased consumption of drugs among the elderly results in greater risk of problems. Läkartidningen 2001; 98: 1674-9.
18. Monane M, Monane S, Semla T. Optimal medication use in elders. Key to successful aging. West J Med 1997; 167: 233-7.
19. Lee RD. Polypharmacy: a case report and new protocol for management. J Am Board Fam Pract 1998; 11: 140-4.
20. Ananth J, Parameswaran S, Gunatilake S. Antipsychotic polypharmacy. Curr Pharm Des 2004; 10: 2231-8.
21. Preskorn SH, Lacey RL. Polypharmacy: when is it rational? J Psychiatr Pract 2007; 13: 97-105.
22. Jensen GL, Friedmann JM, Coleman CD, Smiciklas-Wright H. Screening for hospitalization and nutritional risks among community-dwelling older persons. Am J Clin Nutr 2001; 74: 201-5.
23. Cross RK, Wilson KT, Binion DG. Polypharmacy and Crohn's disease. Aliment Pharmacol Ther 2005; 21: 1211-6.
24. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130-3.
25. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55: 809-17.
26. Alarcon T, Barcena A, Gonzalez-Montalvo JI, Penalosa C, Salgado A. Factors predictive of outcome on admission to an acute geriatric ward. Age Ageing 1999; 28: 429-32.
27. Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol 2006; 62: 151-8.
28. Fincke BG, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Safety 2005; 14: 121-8.
29. Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007; 6: 695-704.
30. Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc 2004; 52: 93-8.
31. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001; 35: 835-40.
32. Flaherty JH, Perry HM, III, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000; 55: M554-M559.
33. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35: 1004-9.
34. Viktil KK, Enstad M, Kutschera J, Smedstad LM, Schjott J. Polypharmacy among patients admitted to hospital with rheumatic diseases. Pharm World Sci 2001; 23: 153-8.
35. Viola R, Csukonyi K, Doro P, Janka Z, Soos G. Reasons for polypharmacy among psychiatric patients. Pharm World Sci 2004; 26: 143-7.
36. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63: 187-95.
37. Perri M, III, Menon AM, Deshpande AD, Shinde SB, Jiang R, Cooper JW, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005; 39: 405-11.
38. Christensen D, Trygstad T, Sullivan R, Garmise J, Wegner SE. A pharmacy management intervention for optimizing drug therapy for nursing home patients. Am J Geriatr Pharmacother 2004; 2: 248-56.
39. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327: 712-7.
40. Klarin I, Fastbom J, Wimo A. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Safety 2003; 12: 669-78.
41. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797-803.
42. Ikaheimo P, Hartikainen S, Tuuponen T, Kiuttu J, Klaukka T. Comorbidity and medication load in adult asthmatics. Scand J Prim Health Care 2005; 23: 88-94.
43. Geest SD, Steeman E, Leventhal ME, Mahrer-Imhof R, Hengartner-Kopp B, Conca A, et al. Complexity in caring for an ageing heart failure population: concomitant chronic conditions and age related impairments. Eur J Cardiovasc Nurs 2004; 3: 263-70.
44. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35: 1004-9.
45. Hayes BD, Klein-Schwartz W, Barrueto F, Jr. Polypharmacy and the geriatric patient. Clin Geriatr Med 2001; 23: 371-90.
46. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945-8.
47. van den Bemt PM, Egberts AC, Lenderink AW, Verzijl JM, Simons KA, van der Pol WS, et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000; 22: 62-6.
48. Stewart RB, Cooper JW. Polypharmacy in the aged. Practical solutions. Drugs Aging 1994; 4: 449-61.
49. Veehof LJG, Meyboom-de JB, Haaijer-Ruskamp FM. Polypharmacy in the elderly - A literature review. Eur J General Pract 2000; 6: 98-106.
50. Blix HS, Viktil KK, Reikvam A, Moger TA, Hjemaas BJ, Pretsch P, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60: 651-8.
51. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817-32.
52. Trygstad TK, Christensen D, Garmise J, Sullivan R, Wegner S. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative. J Manag Care Pharm 2005; 11: 575-83.
53. Myhr R, Kimsas A. [Medication errors when transferring within health care services]. Tidsskr Nor Lœgeforen 1999; 119: 1087-91.
54. Due Larsen M, Nielsen LP, Jeffery L, Staehr ME. Medicineringsfejl ved indleggelse på danske sygehus. Ugeskr Lœger 2006; 168: 2887-90.
55. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957-9.
56. Jackson HD, Mangoni AA, Batty GM. Optimization of drug prescribing. Br J Clin Pharmacol 2004; 57: 231-6.
57. Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Ann Pharmacother 2005; 39: 1785-91.
58. Sloane PD, Gruber-Baldini AL, Zimmerman S, Roth M, Watson L, Boustani M, et al. Medication undertreatment in assisted living settings. Arch Intern Med 2004; 164: 2031-7.
59. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998; 338: 1516-20.